Company Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Company Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

000766

CNE000000735

Pharmaceuticals

Equities

000766

CNE000000735

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Pharmaceuticals

TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
18.86 ^CNY	-0.42%		+9.91%	-5.42%

22/04	Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/04	Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main products consist of Chinese patent drugs, chemical drugs and bulk drugs, among others. The Companyâs products are used in anti-tumor, microbial, digestive system, skeletal and muscle system, gynecology, nervous system and other areas. The Company distributes its products mainly in domestic market.

Number of employees: 1,696

CNY in Million	2022	Weight	2023	Weight	Delta
Biochemical Medicine 59.9 %	908	61.7 %	882	59.9 %	-2.87%
Chinese Patent Medicine 39.3 %	557	37.9 %	579	39.3 %	+3.85%
Active Pharmaceutical Ingredients 0.6 %	5	0.3 %	9	0.6 %	+87.83%
Other 0.2 %	1	0.0 %	4	0.2 %	+516.44%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	1,471	100.0 %	1,473	100.0 %	+0.18%

Managers	Title	Age	Since
Yu Fu Zhang CHM	Chairman	62	16/19/16
Chang You Xu CHM	Chairman	57	01/11/01
Jun Yu DFI	Director of Finance/CFO	53	01/04/01
Huan Wang BRD	Director/Board Member	35	16/19/16
Hong Guang Liu IRC	Investor Relations Contact	-	-
Wei Lin Jia SEC	Corporate Secretary	59	21/02/21

Members of the board	Title	Age	Since
Jun Yu DFI	Director of Finance/CFO	53	01/04/01
Gui Xia Lü BRD	Director/Board Member	56	15/20/15
Chang You Xu CHM	Chairman	57	01/11/01
Yu Fu Zhang CHM	Chairman	62	16/19/16
Ying Jie Wei BRD	Director/Board Member	61	15/20/15
Qiang Zhou BRD	Director/Board Member	59	15/20/15
Huan Wang BRD	Director/Board Member	35	16/19/16
Qi Bin Chen BRD	Director/Board Member	70	21/18/21
Qiu Ting Yin BRD	Director/Board Member	37	15/20/15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	966,494,707	586,594,201 ( 60.69 %)	0	60.69 %

Name	Equities	%	Valuation
Lan Jun Yu 22.65 %	190,000,000	22.65 %	486 M ¥
Shanghai Mukai Trading Co. Ltd. 5.483 %	46,000,000	5.483 %	118 M ¥
Jia Li 4.887 %	40,999,900	4.887 %	105 M ¥
Soochow Securities Co. Ltd.(Investment Mangement) 4.700 %	39,430,000	4.700 %	101 M ¥
Chang Hao Sun 4.649 %	38,999,900	4.649 %	100 M ¥
Xiao Ni Tang 2.503 %	21,000,000	2.503 %	54 M ¥
City of Tonghua 2.384 %	20,000,000	2.384 %	51 M ¥
Wei Wei 2.384 %	20,000,000	2.384 %	51 M ¥
Li Li Han 2.384 %	20,000,000	2.384 %	51 M ¥
Feng Chang Yu 2.384 %	20,000,000	2.384 %	51 M ¥

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.

999 Jinma Road Erdaojiang District

134003, Tonghua

http://www.thjm.cn

address Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd(000766)

	1st Jan change	Capi.
TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD	-5.42%	2.52B
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals